Gravier Pierre 4
4 · PTC THERAPEUTICS, INC. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Gravier Pierre
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-02-15+3,100→ 55,800 total - Award
Common Stock
2024-02-15+19,000→ 52,700 total - Award
Stock Option (Right to Buy)
2024-02-15+47,500→ 47,500 totalExercise: $25.69Exp: 2034-02-14→ Common Stock (47,500 underlying)
Footnotes (3)
- [F1]Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025.
- [F2]Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025.
- [F3]This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.